文献速递针灸推拿中医内科

皮内针治疗肝肾亏虚型类风湿关节炎的假针随机对照试验

Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome - A sham-controlled, randomized, clinical trial.
PubMed 文献 · Complement Ther Med · 2024-04-04

该研究将132例肝肾亏虚型类风湿关节炎患者按1:1分为皮内针组与假皮内针组,观察临床疗效与不良反应。结果显示两组干预前后中医证候评价、HAQ、DAS28及CRP均有统计学差异(P<0.01);皮内针组在中医证候评价、HAQ、DAS28改善上优于假针组(P<0.05),但CRP组间变化无统计学差异(P>0.05),患者未报告不良反应。

要点

  • 皮内针可改善肝肾亏虚型RA的中医证候、HAQ与DAS28,优于假针。
  • 皮内针组与假针组CRP变化无统计学差异(P=0.786)。
  • 上下肢穴位实施结果组内及组间比较无差异,患者未报告不良反应。

核心结论

  • 皮内针干预与降低RA疾病活动度及延缓整体疾病进展相关。

研究设计与样本

  • 假针对照随机临床试验,132例RA患者按1:1分为皮内针组与假皮内针组。

主要发现

  • 两组治疗前后中医证候评价、HAQ、DAS28及CRP均有统计学差异(P<0.01)。
  • 皮内针组中医证候评价改善优于假针组(95%CI [1.14(0.38-1.89)];P=0.001)。
  • 皮内针组HAQ改善优于假针组(95%CI [2.00(1.00-3.00)];P=0.003)。
  • 皮内针组DAS28改善优于假针组(95%CI [0.11(0.02-0.20)];P=0.021)。
  • 两组CRP变化差异无统计学意义(95%CI [0.50(-2.09 to 7.08)],P=0.786)。

关键数值与推荐

  • 上肢与下肢穴位实施结果组内比较:皮内针组P=0.852,假针组P=0.861。
  • 上肢与下肢有效率比较有统计学意义(P=0.001)。

临床怎么用

  • 对肝肾亏虚型RA患者,可考虑皮内针以改善中医证候、HAQ与DAS28。
  • 皮内针在上下肢穴位实施效果无差异,临床取穴可灵活选择。
  • 该研究未报告不良反应,但仍需关注皮内针操作安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Rheumatoid arthritis (RA) is called "immortal cancer", and it affects the quality of life, disability rate and even the survival of patients. This study aimed to observe the clinical efficacy, and adverse reactions of intradermal acupuncture (IA) in the treatment of RA patients with liver and kidney deficiency syndrome. MATERIALS AND METHODS: 132 RA patients were split into an IA group and a sham IA group at a 1:1 ratio. Both groups were assessed before and after the intervention with the assessments: a traditional Chinese medicine (TCM) syndrome evaluation, the Health Assessment Questionnaire (HAQ), the Disease Activity Score 28 (DAS28) and serum C-reactive protein (CRP). RESULTS: There was a statistically significant difference in TCM syndrome evaluation, HAQ, DAS28, and CRP between both groups before and after treatment (P < 0.01). The improvement of TCM syndrome evaluation (95% CI [1.14(0.38-1.89)]; P = 0.001), HAQ (95% CI [2.00(1.00-3.00)]; P = 0.003), and DAS28 (95% CI [0.11(0.02-0.20)]; P = 0.021) in the IA group was more obvious than that in the sham IA group (P < 0.05), except for CRP (95% CI [0.50(- 2.09 to 7.08)], P = 0.786). The difference in CRP outcome changes between the two groups was not statistically significant (P > 0.05). Both groups had comparable results in the implementation of RA in the upper and lower extremity acupoints and did not differ due to different sites (IA group: P = 0.852; sham IA group: P = 0.861). The comparison of effective rate of the upper limb as well as that of the lower limb was statistically significant (P = 0.001). Besides, patients reported no adverse effects. CONCLUSION: The IA intervention was associated with a promising effect on the decrease in RA disease activity and delayed overall disease progression.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Luo H, Du P, Qin W, et al. Intradermal acupuncture in the treatment of rheumatoid arthritis with liver and kidney deficiency syndrome - A sham-controlled, randomized, clinical trial. Complement Ther Med. 2024. PMID: 38582376. doi:10.1016/j.ctim.2024.103037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。